XNASASPI
Market cap371mUSD
Jan 15, Last price
5.21USD
1D
6.11%
1Q
28.96%
IPO
86.07%
Name
ASP Isotopes Inc
Chart & Performance
P/E
—
P/S
858.94
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
433k
Net income
-16m
L+239.92%
CFO
-5m
L+84.10%
Profile
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2019‑12 | |
| Income | ||||
Revenues | 433 | |||
Cost of revenue | 16,475 | 5,172 | ||
Unusual Expense (Income) | ||||
NOPBT | (16,042) | (5,172) | ||
NOPBT Margin | ||||
Operating Taxes | (6) | (154) | ||
Tax Rate | ||||
NOPAT | (16,036) | (5,018) | ||
Net income | (16,286) 239.92% | (4,791) 83.72% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 14,129 | 8,120 | ||
BB yield | -23.87% | -14.31% | ||
| Debt | ||||
Debt current | 869 | 80 | ||
Long-term debt | 2,946 | 1,531 | ||
Deferred revenue | ||||
Other long-term liabilities | 4,298 | |||
Net debt | (4,093) | (779) | ||
| Cash flow | ||||
Cash from operating activities | (5,412) | (2,940) | ||
CAPEX | (2,331) | (4,473) | ||
Cash from investing activities | (2,453) | (4,473) | ||
Cash from financing activities | 13,385 | 6,641 | ||
FCF | (18,953) | (10,102) | ||
| Balance | ||||
Cash | 7,908 | 2,389 | ||
Long term investments | ||||
Excess cash | 7,887 | 2,389 | ||
Stockholders' equity | (21,736) | (6,939) | ||
Invested Capital | 47,008 | 17,579 | ||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 33,067 | 35,907 | ||
Price | 1.79 13.29% | 1.58 | ||
Market cap | 59,189 4.33% | 56,733 | ||
EV | 57,631 | 55,955 | ||
EBITDA | (16,005) | (5,099) | ||
EV/EBITDA | ||||
Interest | 119 | 154 | ||
Interest/NOPBT | ||||